CRD-4730

· Cardurion Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for CRD-4730, covering 2025-07-14 to 2026-02-27. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 2 Study of CRD-4730 in CPVT [Phase 2]